Stem Cells, Bioengineering, Biophysics
General Physics, in collaboration with QB3, and in-house scientists is attempting to develop a synthetic biology approach to 3D printing tissues and organs from stem cell progenitors, chondrocytes, fibroblasts, ECM extrusion, and high throughput industrialization. Stem cell technology in California will revolutionize tailored therapeutics and organ regeneration in the future.
Mammalian Cell and Tissue Culture
General Physics is planning to develop cleanroom facilities and biological fume hood areas where fibroblasts and chondrocytes are grown for deposition in ECM in vitro. Implantation is planned for biological hosts. Therapies will follow after regulations are met and technology is implemented where engineering (not scientific) hurdles are overcome.
Antimicrobial Resistance and New Antibiotics
Treatment of disease, specifically multi-drug resistant bacteria, will require new antibiotics. Sulfa drugs and beta-lactams plus beta-lactamase inhibitors are in the pipeline with General Physics biophysics division working to develop new biochemistry.
Medical Group
General Physics is working to develop a group with specialization in medical physics. Through connections at the UC Berkeley, USC, Trinity School of Medicine, Oakland Children's Hospital, Milton Cato Memorial Hospital, and various locations in the US and abroad, General Physics Corporation and Medical Group physicians and scientists also work in fields as diverse as oncology and orthopedic surgery to medical mycology and genetics.
